TRAF6 Specifically Contributes to FcϵRI-mediated Cytokine Production but Not Mast Cell Degranulation

Yong Jun Yang,Wei Chen,Svetlana O. Carrigan,Wei-Min Chen,Kristy Roth,Taishin Akiyama,Jun-ichiro Inoue,Jean S. Marshall,Jason N. Berman,Tong-Jun Lin
DOI: https://doi.org/10.1074/jbc.m802610200
IF: 5.485
2008-01-01
Journal of Biological Chemistry
Abstract:TRAF6 (tumor necrosis factor-associated factor 6) is an essential adaptor downstream from the tumor necrosis factor (TNF) receptor and Toll-like receptor superfamily members. This molecule is critical for dendritic cell maturation and T cell homeostasis. Here we show that TRAF6 is important in high affinity IgE receptor, FcϵRI-mediated mast cell activation. In contrast to dendritic cells and T cells, TRAF6-deficient mast cells matured normally and showed normal IgE-dependent degranulation. Importantly, TRAF6-deficient mast cells showed impaired production of cytokine interleukin-6, CCL-9, interleukin-13, and TNF following FcϵRI aggregation. Chromatin immunoprecipitation assay showed decreased NF-κB p65 binding to CCL-9 and TNF promoters in TRAF6-deficient mast cells. Antigen and IgE-induced IκB phosphorylation and NF-κB p65 translocation to the nucleus were diminished in TRAF6-deficient mast cells. NF-κB luciferase activity in response to antigen and IgE stimulation was severely impaired in TRAF6-deficient mast cells. In addition, antigen and IgE-induced phosphorylation of mitogen-activated protein kinase p38 and JNK, but not ERK1/2, was significantly reduced in TRAF6-deficient mast cells. These results identified TRAF6 as an important signal transducer in FcϵRI-mediated signaling in mast cells. Our findings implicate TRAF6 as a new adaptor/regulator molecule for allergen-mediated inflammation in allergy.
What problem does this paper attempt to address?